NEBRASKA CLINICAL TRIAL SHOWS
A lot of patients suffering from epilepsy during a clinical trial were treated with cannabis oil showed improvement in their seizures.
The trial was conducted at the University of Nebraska Medical Center in 2015 which highlighting twenty-three participated patients treated with cannabidiol (CBD oil) gained improvement. The patients who participated in this two-year trial were reportedly having epilepsy that regular drugs couldn’t cure.
UNMC's associate Vice Chancellor, Christopher Kratochvil, said the patients with the two most specific forms of epilepsy - Lennox-Gastaut syndrome and Dravet syndrome experienced a remarkable improvement.
The Epidiolex oral solution was the ideal drug used in this study that was approved by FDA in June.
Another student named Brittany Leach said, “I think it's great. I truly think it helps people with seizures and things like that, so I don't see an issue with it. I think it's good.”
Since this newly, soon-to-be-opening café is situated on Campus Corner, it is going to be convenient for students to take a break and relax.
Castor further shared his vision for opening this café. He stated that he wants to educate people on CBD oil, help them take the edge off while making CBD available in a way people will enjoy.